Groundwork BioAg (Linkedin)
Groundwork BioAg, an Israeli agtech startup that produces mycorrhizal inoculants with broad benefits for mainstream agriculture, completed an $18 million Series B round of fundraising led by Climate Innovation Capital (ClimateIC) with participation from HSBC Global Asset Management (HSBC) and BASF Venture Capital.
Israel has always been at the forefront of agtech since the early days of the first Zionist settlements. The country may now be known more as Startup Nation for all of its success in the high tech world. But until recently it was best known for its agricultural innovations.
Groundwork BioAg, a global bioagriculture company, leverages the natural power of mycorrhizal fungi to improve the productivity, sustainability and profitability of commercial agriculture and expand regenerative agriculture practices. Groundwork BioAg is the first to use innovative techniques to solve challenges inherent in high-volume mycorrhizal inoculant production. We will not rest until every hectare of arable land is protected by mycorrhizae and every farmer benefits from higher crop yields while preserving our soils and permanently sequestering carbon.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
The company has established commercial operations across the world’s major breadbaskets, including the United States, Brazil, China, India, Canada, Ukraine, and other countries in Europe, Asia and Africa, to improve the efficiency of major crop production, including corn, soybean, grains, fruits and vegetables.
Groundwork BioAg explains that today, commercial farmers are feeling the effects of intensive cultivation protocols and climate change on soil health. Mycorrhizal inoculants reunite plants with their original partners in growth, enabling farmers to invest in their yields while protecting their investment through plant stress tolerance and long-term soil fertility.
“Building upon our proven science and trusted network of distributors, Groundwork BioAg’s Mycorrhizal BioPlatform, which delivers ROI to both conventional and regenerative farmers while permanently sequestering carbon in their fields, is uniquely positioned to help farmers around the world manage mounting economic and environmental pressures,” said Dr. Yossi Kofman, Co-Founder and CEO of Groundwork BioAg.
